Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
METADATA ONLY
Loading...
Author / Producer
Date
2021-04
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Pancreatic adenocarcinoma (PDAC) epitomizes a deadly cancer driven by abnormal KRAS signaling. Here, we show that the eIF4A RNA helicase is required for translation of key KRAS signaling molecules and that pharmacological inhibition of eIF4A has singleagent activity against murine and human PDAC models at safe dose levels. EIF4A was uniquely required for the translation of mRNAs with long and highly structured 50 untranslated regions, including those with multiple G-quadruplex elements. Computational analyses identified these features in mRNAs encoding KRAS and key downstream molecules. Transcriptome-scale ribosome footprinting accurately identified eIF4A-dependent mRNAs in PDAC, including critical KRAS signaling molecules such as PI3K, RALA, RAC2, MET, MYC, and YAP1. These findings contrast with a recent study that relied on an older method, polysome fractionation, and implicated redox-related genes as eIF4A clients. Together, our findings highlight the power of ribosome footprinting in conjunction with deep RNA sequencing in accurately decoding translational control mechanisms and define the therapeutic mechanism of eIF4A inhibitors in PDAC.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
81 (8)
Pages / Article No.
2002 - 2014
Publisher
American Association for Cancer Research
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Organisational unit
09568 - Rätsch, Gunnar / Rätsch, Gunnar